We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Gear Up for P&G (PG) Q4 Earnings: Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Wall Street analysts expect Procter & Gamble (PG - Free Report) to post quarterly earnings of $1.37 per share in its upcoming report, which indicates no change from the year-ago quarter. Revenues are expected to be $20.73 billion, up 0.9% from the year-ago quarter.
The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
Bearing this in mind, let's now explore the average estimates of specific P&G metrics that are commonly monitored and projected by Wall Street analysts.
Analysts' assessment points toward 'Net sales- Beauty' reaching $3.75 billion. The estimate indicates a year-over-year change of +0.1%.
The collective assessment of analysts points to an estimated 'Net sales- Grooming' of $1.73 billion. The estimate indicates a change of +4.3% from the prior-year quarter.
The consensus estimate for 'Net sales- Corporate' stands at $169.59 million. The estimate points to a change of +3.4% from the year-ago quarter.
The combined assessment of analysts suggests that 'Net sales- Fabric & Home Care' will likely reach $7.32 billion. The estimate suggests a change of +1.1% year over year.
Analysts expect 'Net sales- Baby, Feminine & Family Care' to come in at $5.10 billion. The estimate indicates a year-over-year change of -1%.
Based on the collective assessment of analysts, 'Net sales- Health Care' should arrive at $2.65 billion. The estimate indicates a change of +2.4% from the prior-year quarter.
It is projected by analysts that the 'Organic Sales Growth (YoY change) - Beauty' will reach 2.0%. The estimate compares to the year-ago value of 11%.
The consensus among analysts is that 'Organic Sales Growth (YoY change) - Grooming' will reach 8.8%. The estimate compares to the year-ago value of 8%.
The average prediction of analysts places 'Organic Sales Growth (YoY change) - Total P&G' at 3.1%. Compared to the present estimate, the company reported 8% in the same quarter last year.
According to the collective judgment of analysts, 'Organic Sales Growth (YoY change) - Baby, Feminine & Family Care' should come in at 0.8%. Compared to the current estimate, the company reported 9% in the same quarter of the previous year.
Analysts predict that the 'Organic Sales Growth (YoY change) - Fabric & Home Care' will reach 3.7%. Compared to the present estimate, the company reported 8% in the same quarter last year.
Analysts forecast 'Organic Sales Growth (YoY change) - Health Care' to reach 3.9%. The estimate is in contrast to the year-ago figure of 5%.
P&G shares have witnessed a change of +0.3% in the past month, in contrast to the Zacks S&P 500 composite's -0.3% move. With a Zacks Rank #3 (Hold), PG is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Gear Up for P&G (PG) Q4 Earnings: Wall Street Estimates for Key Metrics
Wall Street analysts expect Procter & Gamble (PG - Free Report) to post quarterly earnings of $1.37 per share in its upcoming report, which indicates no change from the year-ago quarter. Revenues are expected to be $20.73 billion, up 0.9% from the year-ago quarter.
The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
Bearing this in mind, let's now explore the average estimates of specific P&G metrics that are commonly monitored and projected by Wall Street analysts.
Analysts' assessment points toward 'Net sales- Beauty' reaching $3.75 billion. The estimate indicates a year-over-year change of +0.1%.
The collective assessment of analysts points to an estimated 'Net sales- Grooming' of $1.73 billion. The estimate indicates a change of +4.3% from the prior-year quarter.
The consensus estimate for 'Net sales- Corporate' stands at $169.59 million. The estimate points to a change of +3.4% from the year-ago quarter.
The combined assessment of analysts suggests that 'Net sales- Fabric & Home Care' will likely reach $7.32 billion. The estimate suggests a change of +1.1% year over year.
Analysts expect 'Net sales- Baby, Feminine & Family Care' to come in at $5.10 billion. The estimate indicates a year-over-year change of -1%.
Based on the collective assessment of analysts, 'Net sales- Health Care' should arrive at $2.65 billion. The estimate indicates a change of +2.4% from the prior-year quarter.
It is projected by analysts that the 'Organic Sales Growth (YoY change) - Beauty' will reach 2.0%. The estimate compares to the year-ago value of 11%.
The consensus among analysts is that 'Organic Sales Growth (YoY change) - Grooming' will reach 8.8%. The estimate compares to the year-ago value of 8%.
The average prediction of analysts places 'Organic Sales Growth (YoY change) - Total P&G' at 3.1%. Compared to the present estimate, the company reported 8% in the same quarter last year.
According to the collective judgment of analysts, 'Organic Sales Growth (YoY change) - Baby, Feminine & Family Care' should come in at 0.8%. Compared to the current estimate, the company reported 9% in the same quarter of the previous year.
Analysts predict that the 'Organic Sales Growth (YoY change) - Fabric & Home Care' will reach 3.7%. Compared to the present estimate, the company reported 8% in the same quarter last year.
Analysts forecast 'Organic Sales Growth (YoY change) - Health Care' to reach 3.9%. The estimate is in contrast to the year-ago figure of 5%.
View all Key Company Metrics for P&G here>>>
P&G shares have witnessed a change of +0.3% in the past month, in contrast to the Zacks S&P 500 composite's -0.3% move. With a Zacks Rank #3 (Hold), PG is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>